Palliative thoracic radiotherapy for lung cancer: A systematic review

Journal of Clinical Oncology

Volumn 26, Issue 24, 2008, Pages 4001-4011

  Fairchild, Alysa ^a   Harris, Kristin ^a   Barnes, Elizabeth ^a   Wong, Rebecca ^a   Lutz, Stephen ^a   Bezjak, Andrea ^a   Cheung, Patrick ^a   Chow, Edward ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; DOSIMETRY; DYSPHAGIA; HUMAN; INFORMATION TECHNOLOGY; LUNG CANCER; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; AGED; FEMALE; LUNG TUMOR; MALE; META ANALYSIS; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL;

AGED; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 50549094169     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.3312     Document Type: Review

References (34)

1. Sirzén F, Kjellen E, Sorenson S, et al: A systematic overview of radiation therapy effects in non-smallcell lung cancer. Acta Oncol 42:493-515, 2003
2. Hoegler D: Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer 21:129-183, 1997
3. Coia LR, Hanks GE, Martz K, et al: Practice patterns of palliative care for the United States, 1984-1985. Int J Radiat Oncol Biol Phys 14:1261-1269, 1988
4. British Columbia Cancer Agency Cancer Management Guidelines: Non-Small Cell Lung Cancer. http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Lung/ 6ManagementPolicies/641NonSmallCellLungCancer/ 13PalliativeRadiotherapyforLocallyAdvancedandMetastaticNSCLS.htm
5. ASCO clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 15:2996-3018, 1997
6. Brundage M, Bezjak A, Dixon P, et al: The role of palliative thoracic radiotherapy in non-small-cell lung cancer. Can J Oncol 6:25-32, 1996 (suppl 1)
7. Langendijk JA, ten Velde GP, Aaronson NK, et al: Quality of life after palliative radiotherapy in non-small cell lung cancer: A prospective study. Int J Radiat Oncol Biol Phys 47:149-155, 2000
8. Simpson JR, Francis ME, Perez-Tamayo R, et al: Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11:751-758, 1985
9. Teo P, Tai TH, Choy D, et al: Randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 14:867-871, 1988
10. Medical Research Council Lung Cancer Working Party: Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 63:265-270, 1991
11. Medical Research Council Lung Cancer Working Party: A Medical Research Council (MRC) randomized trial of palliative radiotherapy with two fractions of a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 65:934-941, 1992
12. Abratt RP, Shepherd LJ, Mameena Salton DG: Palliative radiation for stage 3 non-small cell lung cancer: A prospective study of two moderately high dose regimens. Lung Cancer 13:137-143, 1995
13. Medical Research Council Lung Cancer Working Party: Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol (R Coll Radiol) 1996;8:167-175, 1996
14. Rees GJ, Devrell CE, Barley VL, et al: Palliative radiotherapy for lung cancer: Two versus five fractions. Clin Oncol (R Coll Radiol) 9:90-95, 1997
15. Nestle U, Nieder C, Walter K, et al: A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs conventionally fractionated 60Gy: Results of a randomized equivalence study. Int J Radiat Oncol Biol Phys 48:95-103, 2000
16. Bezjak A, Dixon P, Brundage M, et al: Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC. 15). Int J Radiat Oncol Biol Phys 54:719-728, 2002
17. Sundstrøm S, Bremnes R, Aasebo U, et al: Hypofractionated palliative radiotherapy (17Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial. J Clin Oncol 22:801-810, 2004
18. Erridge SC, Gaze MN, Price A, et al: Symptom control and quality of life in people with lung cancer: A randomized trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 17:61-67, 2005
19. Kramer GW, Wanders SL, Noordijk EM, et al: Results of the Dutch national study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol 23:2962-2970, 2005
20. Senkus-Konefka E, Dziadziuszko, Bednaruk-Mlynski E, et al: A prospective, randomized study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Br J Cancer 92:1038-1045, 2005
21. Toy E, Macbeth F, Coles B, et al: Palliative thoracic radiotherapy for non-small-cell lung cancer: A systematic review. Am J Clin Oncol 26:112-120, 2003
22. Lester JF, Macbeth FR, Toy E, et al: Palliative radiotherapy regimens for non-small-cell lung cancer. Cochrane Database Syst Rev 4:CD002143, 2006
23. Okawara G, Mackay J, Evans W, et al: Management of unresected stage III non-small cell lung cancer: A systematic review. J Thorac Oncol 1:377-393, 2006
24. Timothy A, Girling D, Saunders M, et al: Consensus statement: Radiotherapy for inoperable lung cancer. Clin Oncol (R Coll Radiol) 13:86-87, 2001
25. Scottish Intercollegiate Guidelines Network: Management of patients with lung cancer: A national clinical guideline. http://www.sign.ac.uk/pdf/sign80.pdf
26. Graham MV: Non-aggressive, non-surgical treatment of inoperable NSCLC. Radiology 215:1347-1362, 2000 (suppl)
27. NationalComprehensiveCancer Network: Treatment guidelines - NCCN Clinical Practice Guidelines in Oncology Non-Small Cell Lung Cancer V.2, 2008. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf
28. Tjan-Heijnen V, Groen H, Schramel F, et al: Consensus conference on palliative treatment of stage IV non-small cell lung cancer. Neth J Med 58:52-61, 2001
29. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
30. Wu JSY, Wong R, Johnston M, et al: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594-605, 2003
31. Reinfuss M, Glinski B, Kowalska T, et al: Radiotherapy for stage III, inoperable, asymptomatic small cell lung cancer: Final results of a prospective randomized study (240 patients) [in French]. Cancer Radiother 3:475-479, 1999
32. Townsend PW, Rosenthal HG, Smalley SR, et al: Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 12:2345-2350, 1994
33. Bruera E, Willey J, Ewert-Flannagan P, et al: Pain intensity assessment by bedside nurses and palliative care consultants: A retrospective study. Support Care Cancer 13:228-231, 2005
34. Chow E, Wu JSY, Hoskin P, et al: International consensus on palliative radiotherapy endpoints for future clinical trials on bone metastases. Radiother Oncol 64:275-280, 2002